ProPhase Labs Inc (NASDAQ:PRPH)’s traded shares stood at 1.07 million during the latest session, with the company’s beta value hitting -0.25. At the last check today, the stock’s price was $5.80, to imply a decrease of -7.50% or -$0.47 in intraday trading. The PRPH share’s 52-week high remains $9.94, putting it -71.38% down since that peak but still an impressive 30.17% since price per share fell to its 52-week low of $4.05. The company has a valuation of $104.69M, with an average of 30.66K shares over the past 3 months.

ProPhase Labs Inc (NASDAQ:PRPH) trade information

After registering a -7.50% downside in the latest session, ProPhase Labs Inc (PRPH) has traded red over the past five days. The stock hit a weekly high of 7.48, dropping -7.50% in its intraday price action. The 5-day price performance for the stock is -9.38%, and 10.90% over 30 days. With these gigs, the year-to-date price performance is 28.32%.

ProPhase Labs Inc (PRPH) estimates and forecasts

Looking at statistics comparing ProPhase Labs Inc share performance against respective industry, we note that the company has underperformed competitors. ProPhase Labs Inc (PRPH) shares are 29.46% up over the last 6 months, with its year-to-date growth rate lower than industry average at 9.18% against 9.60%. Revenue is forecast to shrink -1,466.70% this quarter before falling -105.00% for the next one. The rating firms project that company’s revenue will shrink -51.40% compared to the previous financial year.

Revenue forecast for the current quarter as set by 1 analysts is $4 million. Meanwhile, for the quarter ending Jun 2024, a total of 1 analyst(s) estimate revenue growth to $4 million.Earnings reports from the last fiscal year show that sales brought in $19.3 million and $14.14 million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -79.30% before dropping -71.70% in the following quarter.

PRPH Dividends

ProPhase Labs Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. ProPhase Labs Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.